Echenevex, France

Raphael Campanella

This inventor holds 1 USPTO granted patent. Top assignee: Bracco Imaging S.p.a.. Active years: 2020.


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Raphael Campanella: Innovator in NIR Fluorescent Probes

Introduction

Raphael Campanella is a notable inventor based in Échenevex, France. He has made significant contributions to the field of medical imaging through his innovative work on fluorescent probes. His expertise and dedication to advancing technology in guided surgery have positioned him as a key figure in his industry.

Latest Patents

Campanella holds a patent for the "Solid phase synthesis of NIR fluorescent probe." This invention discloses a solid-phase process for the preparation of a Near Infra-Red (NIR) fluorescent probe. The probe is characterized by an aza-bicycloalkane based cyclic peptide labeled with a Cy5.5 dye moiety. It is specifically designed for use in the guided surgery of tumors and pathologic regions. This patent highlights his commitment to improving surgical outcomes through innovative technology.

Career Highlights

Raphael Campanella is associated with Bracco Imaging S.p.A., a company known for its advancements in medical imaging. His work at Bracco Imaging has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Some of his notable coworkers include Anthony Clouet and Luciano Lattuada. Their collaboration has fostered an environment of innovation and creativity, leading to advancements in medical imaging technologies.

Conclusion

Raphael Campanella's contributions to the field of NIR fluorescent probes exemplify his dedication to innovation in medical technology. His work not only enhances surgical practices but also showcases the importance of collaboration in advancing scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…